Skip to main content
. 2020 Aug 12;2020(8):CD000543. doi: 10.1002/14651858.CD000543.pub5
Study Reason for exclusion
Adrizzone 2006 Ineligible comparator group (AZA)
Ahluwalia 1992 Not a randomized control trial
Behrens 2013 No control group
Dignass 2018 No control group (both groups received 1000 mg mesalamine a day)
Fiorino 2019 The study drug was not pure 5‐ASA, but also contained sodium hyaluronate
Gross 2011 Ineligible comparator group (Budesonide)
Irvine 2008 Not a randomized control trial
Kamm 2009 Not a randomized control trial
Levine 2017 Not an oral 5‐ASA formulation
Mahmood 2005 Not an oral 5‐ASA formulation
Paoluzi 2002 No control group
Park 2018 Maintenance study
Pruitt 1991 Not a randomized control trial
Rubin 2017 Compares once‐daily budesonide to placebo in people who are refractory to 5‐ASA treatment
Safdi 1997 Not an oral 5‐ASA formulation
Suzuki 2017 Not an induction trial
Turner 2017 A pediatric study
Vecchi 2001 Not an oral 5‐ASA formulation
Vernia 2000 No control group
Ye 2018 No control group (both groups received same oral regimen)
Yoshimura 2018 No control group